American depositary receipts (ADRs) of Philips (PHG) advanced as the health technology firm posted better-than-expected results and raised its outlook on improved operational performance.
Dutch medical device maker Philips raised its 2023 earnings outlook on Monday after posting stronger third quarter sales and profits despite a recent setback for its sleep machines in the United State
Philips CEO Roy Jakobs discusses the company's third-quarter results and the outlook for China.
Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than doubling of third-quarter core profit to 457 million euros ($483.3 milli
Koninklijke Philips' (PHG) third-quarter results are likely to reflect strength in the Diagnosis & Treatment and Connected Care segments amid macroeconomic challenges.
Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confidence.

Koninklijke Philips: Hold For Now

12:10am, Thursday, 12'th Oct 2023
Exor recently entered Philips with a 15% equity stake (and optionality to arrive at 20%). PHG agrees to conduct additional testing and notes ongoing communication and cooperation with the FDA. Here at
American depositary receipts (ADRs) of Koninklijke Philips (PHG) sank in early trading on Friday as the Food and Drug Administration (FDA) ruled the Netherlands-based health tech firm's handling of a
Shares of Royal Philips (PHG) tumbled in early trading on Friday after the U.S. Food and Drug Administration said it was not satisfied with how the company handled a recall of its breathing device tha
Philips said it would do the additional testing the FDA is requiring. The company recently settled some claims regarding the recalled products but faces other legal challenges.

Philips Stock Sinks Amid FDA Accusations

09:04am, Friday, 06'th Oct 2023
The shares of Koninklijke Philips NV (NYSE:PHG) are plummeting in premarket trading this morning, as the Dutch healthcare tech company comes under fire from the U.S. Food and Drug Administration (FDA)
Shares of Dutch health tech company Philips fell on Friday after the U.S. drug regulator deemed its handling of a major product recall inadequate.
The U.S. Food and Drug Administration (FDA) remains unsatisfied with the status of a product recall by healthcare technology company Philips , the regulator said in an update.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Royal Philips NV CEO Roy Jakobs talks about the the consequences of recalling sleep apnea devices. He says the Dutch maker of medical gear has not put out a final figure on the cost of the recall, bu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE